Cognitive Biotype: A Novel Depression Subcategory Defying Conventional Treatments Identified

Researchers discovered a new depression subtype, the 'cognitive biotype,' affecting 27% of patients who respond poorly to typically prescribed antidepressants.

Related Keywords

Westmead ,New South Wales ,Australia ,Sydney ,Leanne Williams ,Emily Moskal ,Sierra Pacific Mental Illness Research ,Precision Mental Health ,Stanford University Clinical ,Clinical Center ,Veterans Affairs Palo Alto Health Care System ,World Health Organization Quality Of Life ,Stanford Translational Precision Mental Health Clinic ,Translation Science Award Program ,National Center ,Translational Sciences ,National Institutes Of Health ,Brain Dynamic Centre ,Stanford University Innovative Medicines Accelerator ,Westmead Institute For Medical Research ,Brain Resource Company Operations Pty Ltd ,Stanford Center ,University Of Sydney ,Stanford Medicine ,Laura Hack ,Stanford University Innovative Medicines ,Westmead Institute ,Medical Research ,Brain Resource Company Operations Pty ,Stanford University ,Advancing Translational Sciences ,National Institutes ,Cognitive Biotype ,Behavior Measures ,Neural Circuits ,Differential Treatment ,International Study ,Predict Optimized Treatment ,Occupational Functioning Assessment Scale ,World Health Organization Quality ,Neuroscience Newsletter ,